$JNJ J&J loses talc case in New Jersey Johnson
Post# of 129
Johnson & Johnson (NYSE:JNJ) suffers its first trial loss in a lawsuit claiming its talc-based products contain cancer-causing asbestos. A New Jersey jury on Thursday ordered J&J and another company to pay $37M in damages.
The plaintiff was New Jersey resident Stephen Lanzo who developed mesothelioma after inhaling dust that was generated through his regular use of J&J talc powder products. J&J denied all the allegations.
J&J faces talc-related lawsuits by 6,610 plaintiffs nationally. In five trials in Missouri involving ovarian cancer lawsuits, juries found J&J liable four times and awarded the plaintiffs a total of $307M. In California, a jury awarded a now-deceased woman $417M.
Shares are down 1% premarket.
Johnson & Johnson (JNJ) Stock Research Links
Join Webull today and get up to 75 #FREE stocks!
Get started >> Register with my referral link now>> JOIN HERE NOW
CLICK TO SEE --> Engineer, Design,& Build Packaging Equipment